Evaluation of antiarrhythmia drug through QSPR modeling and multi criteria decision analysis
- PMID: 40783645
- PMCID: PMC12335508
- DOI: 10.1038/s41598-025-14892-2
Evaluation of antiarrhythmia drug through QSPR modeling and multi criteria decision analysis
Abstract
This study explores how topological indices (TIs), which are mathematical descriptors of a drug's molecular structure, can support to predict vital properties and biological activities. This understanding is a key for more effective drug design. We focused on drugs used to treat several arrhythmia conditions, including tachycardias, bradycardias, and premature beats. Our approach combines molecular modeling with decision-making techniques to offer a cost-effective way to understand how these drug molecules behave. Our procedure started with calculating topological indices for the chemical structures of these medications to extract information about their features. We then established quantitative structure-property relationship (QSPR) models using quadratic regression, training and validating them. We concentrated on TIs that showed a strong correlation[Formula: see text] with physicochemical properties. Each property was also weighted, based on its correlation with the topological indices. As a final point, to aid in informed decision-making, we employed multiple-criteria decision-making approaches Technique for Order Preference by Similarity to Ideal Solution TOPSIS and Simple Additive Weighting SAW to rank the anti- arrhythmia medications. Drug Amiodarone ranked highest due to strong correlation with boiling point and polarizability. The study also highlights the potential of machine learning to analyze large datasets, allowing for accurate predictions of chemical behavior. This comprehensive method can facilitate the detection of new drugs with valuable qualities and improve our understanding of how chemical structures affect drug effectiveness.
Keywords: Correlation coefficient; Heatmap; MCDM; QSPR analysis; SAW; TOPSIS; Topological indices.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures





Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Exploring entropy measures with topological indices on colorectal cancer drugs using curvilinear regression analysis and machine learning approaches.PLoS One. 2025 Jul 9;20(7):e0327369. doi: 10.1371/journal.pone.0327369. eCollection 2025. PLoS One. 2025. PMID: 40632824 Free PMC article.
-
Patient buy-in to social prescribing through link workers as part of person-centred care: a realist evaluation.Health Soc Care Deliv Res. 2024 Sep;13(27):1-17. doi: 10.3310/ETND8254. Health Soc Care Deliv Res. 2024. PMID: 39344953
-
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119. Online ahead of print. Health Technol Assess. 2025. PMID: 40580049 Free PMC article.
-
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3. Cochrane Database Syst Rev. 2014. PMID: 24777444 Free PMC article.
References
-
- Zipes, D. P. & Wellens, H. J. Sudden cardiac death. Circulation98(21), 2334–2351 (1998). - PubMed
-
- Camm, A. J. et al. Guidelines for the management of atrial fibrillation. Eur. Heart J.31(19), 2369–2429 (2010). - PubMed
-
- Dan, G. A. et al. ESC Scientific Document Group Sticherling Christian (Reviewer Coordinator) Ehrlich Joachim R Schilling Richard Pavlovic Nikola De Potter Tom Lubinski Andrzej Svendsen Jesper Hastrup Ching Keong Sapp John Lewis Chen-Scarabelli Carol Martinez Felipe. Antiarrhythmic drugs-clinical use and clinical decision making: A consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) working group on cardiovascular pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and international society of cardiovascular pharmacotherapy (ISCP). Ep Europace20(5), 731–732 (2018). - PubMed
-
- Karunarathna, I. et al. Atenolol in special populations: Considerations for renal impairment and diabetes. Uva Clin. Anaesth. Intens. Care1(1), 1–10 (2024).
-
- Maysitha, B. K. Comparison of the use of bisoprolol and metoprolol in heart failure patients systematic review study. J. Pharm. Care Anwar Med.5(2), 31–39 (2024).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials